Misfortunes and accusations against one of the most famous Corona vaccines

Despite the confirmation of the World Health Organization and regulators in Europe, that there was no reason to stop its use, the Dutch government announced, on Sunday, the suspension of the use of the “AstraZeneca” vaccine against the emerging corona virus, until at least March 29, as a precautionary measure, for the Netherlands to join To other countries have taken similar steps.

In detail, the Dutch government revealed that the move was based on reports from Denmark and Norway of potentially dangerous side effects.

"Based on new information, the Dutch Medicines Authority has advised, in a precautionary measure and pending a more in-depth investigation, to suspend the administration of the AstraZeneca vaccine against Covid-19," she said in a statement.

This came after the Norwegian health authorities announced, on Saturday, that three of their health workers were receiving treatment in hospitals as a result of bleeding, blood clots and a low number of platelets.

In turn, Ireland revealed, on Sunday, that it had decided to suspend the use of the vaccine, after reports of it causing serious complications to some of those who received it.

And local media, in Ireland, reported that the National Advisory Committee on Immunization had recommended that the use of the vaccine, developed by the British Swedish pharmaceutical company in cooperation with the British University of Oxford, be temporarily suspended until its safety is further confirmed.

We didn't see any problems!

On the other hand, AstraZeneca confirmed on Sunday that it had reviewed those who had been vaccinated with its vaccine and had not detected any risk of blood clots.

It added in a statement that the reviews included 17 million people who had been vaccinated in the European Union and Britain

And according to what the developer announced, the analysis of data belonging to more than 10 million people showed that there are no risks for any age group or any batch of vaccine doses.

In addition, the European Union Medicines Regulatory Authority indicated that European countries can continue to use the vaccine, while cases of blood clots are being investigated, which prompted some countries to suspend its use.

The European Medicines Agency said in a statement that the position of the Agency's Safety Committee is that the benefits of the vaccine remain outweigh the risks and can continue to be administered while the cases of thromboembolism are investigated.

the least expensive

It is worth noting that the AstraZeneca vaccine is among the least expensive and represents the bulk of the vaccines delivered to the world's poorest countries under the WHO-supported Kovacs initiative, which aims to ensure an equal distribution of vaccines worldwide.

Meanwhile, large-scale vaccination campaigns are crucial to ending the pandemic that has killed more than 2,6 million people worldwide.